Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
CALL
SLM Corp
SLM
$5.15B
| $938K | ﹤0.01% |
83,000
+1,800
| +2% | +$19.7K |
|
|
AUY
3127
CALL
DELISTED
Yamana Gold, Inc.
AUY
| $937K | ﹤0.01% |
300,200
+109,500
| +57% | +$292K |
|
|
DM
3128
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $937K | ﹤0.01% |
30,768
+8,478
| +38% | +$267K |
|
3129
CALL
Calumet Specialty Products
CLMT
$3.44B
| $936K | ﹤0.01% |
121,500
-50,900
| -30% | -$424K |
|
3130
Green Plains
GPRE
$1.03B
| $935K | ﹤0.01% |
55,517
-78,665
| -59% | -$1.38M |
|
3131
Malibu Boats
MBUU
$567M
| $935K | ﹤0.01% |
31,417
-16,722
| -35% | -$510K |
|
3132
PUT
Invesco DB US Dollar Index Bullish Fund
UUP
$413M
| $935K | ﹤0.01% |
38,900
+3,000
| +8% | +$73.1K |
|
|
HEP
3133
DELISTED
Holly Energy Partners, L.P.
HEP
| $935K | ﹤0.01% |
28,789
+1,853
| +7% | +$61.6K |
|
|
CY
3134
DELISTED
Cypress Semiconductor
CY
| $935K | ﹤0.01% |
61,414
+51,164
| +499% | +$813K |
|
|
TGP
3135
PUT
DELISTED
Teekay LNG Partners L.P.
TGP
| $933K | ﹤0.01% |
46,300
-26,900
| -37% | -$489K |
|
3136
Cerus
CERS
$474M
| $932K | ﹤0.01% |
275,661
+120,272
| +77% | +$407K |
|
3137
CALL
Tronox
TROX
$1.04B
| $931K | ﹤0.01% |
45,400
+44,400
| +4,440% | +$1.08M |
|
3138
PUT
NCR Voyix
VYX
$1.14B
| $931K | ﹤0.01% |
44,662
+3,260
| +8% | +$66.2K |
|
3139
Wabtec
WAB
$49.3B
| $931K | ﹤0.01% |
11,422
-2,484
| -18% | -$190K |
|
|
JUNO
3140
CALL
DELISTED
Juno Therapeutics, Inc.
JUNO
| $928K | ﹤0.01% |
20,300
+9,600
| +90% | +$479K |
|
3141
PUT
Kinder Morgan
KMI
$68.7B
| $927K | ﹤0.01% |
51,300
-141,000
| -73% | -$2.53M |
|
3142
Stepan Co
SCL
$1.48B
| $927K | ﹤0.01% |
11,747
+8,557
| +268% | +$703K |
|
|
ONIT
3143
Onity Group
ONIT
$332M
| $927K | ﹤0.01% |
19,728
+9,055
| +85% | +$454K |
|
3144
MarketAxess Holdings
MKTX
$5.72B
| $926K | ﹤0.01% |
4,590
+3,892
| +558% | +$734K |
|
|
IMMU
3145
PUT
DELISTED
Immunomedics Inc
IMMU
| $926K | ﹤0.01% |
57,300
+26,400
| +85% | +$312K |
|
3146
Cathay General Bancorp
CATY
$4.24B
| $925K | ﹤0.01% |
21,928
+12,413
| +130% | +$518K |
|
|
SGEN
3147
DELISTED
Seagen Inc. Common Stock
SGEN
| $925K | ﹤0.01% |
17,316
+9,322
| +117% | +$545K |
|
3148
B&G Foods
BGS
$286M
| $924K | ﹤0.01% |
26,276
+18,453
| +236% | +$632K |
|
3149
PUT
EQT Corp
EQT
$32.3B
| $922K | ﹤0.01% |
29,759
+21,676
| +268% | +$711K |
|
|
CVA
3150
DELISTED
Covanta Holding Corporation
CVA
| $922K | ﹤0.01% |
54,620
+42,071
| +335% | +$649K |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.